使用FAERS数据 (2004-2024) 对罗皮瓦卡因安全性的药监测评估
Congcong Lai1, Zengguang Bao1, Zenan Chen1
1Department of Anesthesiology, Xiangshan Hospital of TCM Medical and Health Group, Ningbo, China.
Medicine
|December 10, 2025
概括
罗皮瓦卡因是一种常见的局部麻醉剂,与安全问题有关,包括神经和心脏事件,主要是在使用后72小时内. 对不良事件 (AE) 的人口层面分析突出了需要进一步调查的潜在的性别特异性模式.
科学领域:
- 药物监督 药物监督 药物监督
- 麻醉学 麻醉学
- 药品安全 药品安全
背景情况:
- 罗皮瓦卡因 (ropivacaine) 是一种长效局部麻醉剂的广泛临床使用.
- 对于ropivacaine,在人口层面上仅有有限的安全数据.
- 需要对与罗皮瓦卡因相关的不良事件 (AE) 进行全面分析.
研究的目的:
- 使用美国食品和药物管理局不良事件报告系统 (FAERS) 分析和分类与罗皮瓦卡因相关的AE.
- 确定与罗皮瓦卡因相关的药物不良事件 (ADEs) 的重要安全信号和模式.
主要方法:
- 从FAERS (2004-2024) 中回顾提取罗皮瓦卡因ADE报告.
- 不成比例分析 (ROR,PRR,BCNN,EBGM) 用于评估AE协会.
- 韦布尔形状参数和卡普兰-梅尔方法用于时间到发病分析.
主要成果:
- 发现了1463个罗皮瓦卡因AE报告;检测到181个阳性ADEs.
- 常见的ADE包括麻醉并发症,霍纳综合征,延迟唤醒,局部麻醉系统毒性和单衰.
- 发病的中位时间为2天,观察到早期失败模式.
结论:
- 罗皮瓦卡因显著的安全信号,特别是神经和心脏事件在72小时内.
- 潜在的性别特异性报告模式需要进一步的临床研究.
- 现实世界的数据为有针对性的监测和对罗皮瓦卡因安全性的未来研究提供了证据.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
229
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
229
Local Anesthetics: Pharmacokinetics
1.1K
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
1.1K
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Analysis of Population Pharmacokinetic Data
653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653


